Johnson & Johnson's consumer health business may have turned the corner on its recovery from manufacturing struggles that ended nearly three years ago with a clean bill of health from FDA as orders for OTC drugs increase and e-commerce boosts for personal care product sales.
Analysts say J&J's consumer business results for the first quarter were "encouraging" for its long-term outlook after its worldwide consumer...






